Capital, code, and orbit: the US–China contest moves from chips to listings
On the morning of 11 June 2026, two stories landed within minutes of each other on the same wire, and together they redrew the geography of the US–China technology contest. South China Morning Post reported that Chinese state-affiliated insurers are now underwriting the launch failures of private Chinese rockets built to challenge SpaceX. Within the hour, Nikkei Asia filed that China's AI laboratories are digging in for a multi-year funding race, even as their US counterparts — SpaceX among them — queue for what may be the most consequential IPO window in a decade. Read separately, each is a market note. Read together, they describe a transition: the rivalry between Washington and Beijing is migrating from the chip-fab and the export-control list to the listing document, the insurance policy and the orbital slot.
The shift matters because the plumbing of capital is where this contest will now be won or lost. Export controls can slow a Chinese foundry for a quarter; they cannot, on their own, fund a domestic substitute at scale. Only patient money — sovereign, corporate, and the risk-tolerant kind that buys IPOs — can do that. The two articles published on Thursday describe, almost in real time, both sides of that equation: a Chinese state-backed risk industry learning to absorb rocket failures the way Lloyd's once absorbed marine losses, and a Chinese AI sector preparing to match Wall Street's appetite for compute-heavy listings with its own pipeline of state-supported, domestically integrated champions.
Beijing learns to price risk
The more novel of the two pieces is SCMP's account of Chinese insurers stepping into the launch market. For most of the commercial space era, the United States has had an almost monopolistic position in orbital insurance. Western underwriters, anchored in London and backed by reinsurance markets in Bermuda and Zurich, priced the premiums that made a failed Falcon 9 survivable for a paying customer. Chinese private launchers — names like Galactic Energy, iSpace, LandSpace, Orienspace and the longer-established CAS Space — have grown rapidly over the past three years, but their domestic customer base has been reluctant to fly on a vehicle whose loss would not be covered. State-owned satellites, in particular, were effectively barred from riding Chinese private rockets because no Chinese underwriter would write the policy.
According to SCMP's 11 June report, that is changing. Chinese insurers with state-affiliated capital are now willing to underwrite the loss of payload and vehicle for launches flown by Chinese private operators, on terms that domestic satellite operators can accept. The structural significance is that the launch market is no longer gated by access to Western insurance capacity. A Chinese communications-satellite operator can now place a payload on a Chinese private rocket, insured by a Chinese underwriter, with no foreign-currency exposure and no dependency on Lloyd's syndicate appetite.
The Chinese position, as conveyed through the state-aligned outlets that have covered the buildout, is that this is a routine maturation of a domestic industry. A senior Beijing-based space economist quoted in Chinese state media has argued, in the standard formulation, that a sovereign launch industry requires a sovereign insurance market — and that the absence of one was a historical accident of underwriting geography, not a permanent feature of the global financial architecture. Western commentators, including analysts at the Center for Strategic and International Studies and the Atlantic Council, have framed the same development as industrial-policy on a third front: subsidies for rockets, subsidies for launch pads, and now subsidies for risk. Both readings have weight. The state-affiliated insurers are not pricing these policies on a pure-actuarial basis; they are, in the language of the SCMP piece, absorbing the first-loss layer in order to seed a market. That is what state development banks did for China's high-speed rail in the 2000s, and what the policy banks did for the EV sector a decade later.
Wall Street's window, Beijing's response
The second piece, filed by Nikkei Asia on the same morning, is in some ways the more conventional story: a queue of US AI and space companies preparing to go public, with SpaceX cited as the marquee name. The framing — Chinese AI firms digging in, US rivals heading for an IPO bonanza — is the familiar rhythm of alternating cycles. But Nikkei's reporting carries a sharper undertone. Chinese AI laboratories, in the piece's account, are not pretending that a single listing will change the balance. They are reorganising around domestic compute, domestic capital, and a multi-year horizon in which the listing window is incidental rather than determinative.
That posture is consistent with what the SCMP opinion desk argued in a companion piece on 11 June: that the symbolic weight of a tech IPO in China now rivals its weight in the United States. Where a 2018-era Chinese tech founder might have seen a Nasdaq listing as the only credible validation, the 2026 cohort is increasingly content with a Hong Kong or Shanghai STAR Market listing, on terms that keep the company inside the domestic capital ecosystem and inside the regulatory perimeter of the People's Bank of China and the China Securities Regulatory Commission. The SCMP piece notes that several of the largest Chinese AI and chip-design companies that listed domestically in the past 18 months now trade at premiums to their US-listed comparables, once onshore-offshore liquidity differentials are normalised.
The Western framing of this story, dominant in the New York and London press, is that the US retains the deepest pool of risk capital and the most sophisticated secondary market, and that any decoupling imposes costs on China that Beijing is underestimating. The Chinese counter-framing, articulated in the pages of the Global Times and the Securities Times, is that the US capital market is itself a captive of a small number of mega-cap tech issuers, that antitrust and labour-market frictions are rising, and that the marginal Chinese listing is now more useful inside a renminbi-denominated system than outside it. Both framings are partially true. The data point that sits between them — and that the source items do not resolve — is the price at which China's sovereign wealth funds, the National Council for Social Security Fund, and the policy banks will continue to absorb the risk that retail and foreign capital will not.
The chip stack is upstream, the listing is downstream
The temptation in 2026 is to read every US–China technology story through the lens of export controls — the October 2022 chip rules, the October 2023 refresh, the December 2024 AI-diffusion rule, the May 2026 BIS update on advanced lithography. Those rules are real, and they continue to bite. SMIC's progress on the 5-nanometre node, Huawei's Ascend series, and Cambricon's listing trajectory are all shaped by what NVIDIA, ASML and TSMC can and cannot sell into the mainland. The SCMP and Nikkei items do not dispute that. What they add is a second register: a system in which the cost of being cut off from Western capital is being offset, in real time, by the construction of a parallel capital stack.
The shape of that stack is now legible. At the base sits the policy-bank lending that built the fabs and the launch pads. Above that sits a domestic insurance industry that can price the risk of a Long March failure or a foundry delay. Above that sits a primary equity market, in Hong Kong and on the STAR Market, that is willing to assign double-digit-billion-dollar valuations to AI labs whose US comparables are in retreat. And above that sits a sovereign wealth complex — CIC, SAFE, the National Social Security Fund — that is willing to be the marginal buyer when the marginal foreign buyer steps away. The October 2022 export-control regime was designed to compress the top of this stack. The 2026 evidence, in the two articles published on 11 June, is that the stack has continued to thicken underneath it.
The orbital race is a financial race
The two stories also share a telling detail. SpaceX appears in both, and in neither case is it the protagonist. In the SCMP piece, SpaceX is the comparator — the Western incumbent whose launch cadence the Chinese private sector is now matching with the help of state-backed insurance. In the Nikkei piece, SpaceX is the listing candidate whose IPO will set the price for an entire category. In neither story is SpaceX the agent of a US national strategy in the way, say, the Apollo programme once was. The closest US equivalent to the Chinese model — patient state-adjacent capital underwriting the risk of frontier industries — is the Department of Defense's portfolio of launch-service-procurement contracts, and the small but growing universe of Pentagon-aligned venture funds. Those are real, but they are not yet at the scale of the Chinese state-affiliated insurance market that SCMP describes.
The orbital economy, in other words, is becoming a financial economy in which the question is not who can build a reusable first stage, but who can underwrite the loss when one explodes on the pad. China, on the evidence of the 11 June reporting, is now willing to do that for its own operators. The United States, on the same evidence, is willing to monetise the success of its leading operator in a way that no Chinese company has yet been allowed to. The two are not symmetrical. They are, however, both recognisable answers to the same question: how does a great power fund the next generation of dual-use technology without asking its taxpayers to underwrite every failure?
Stakes, and what remains unresolved
The contest that the 11 June reporting describes is, at root, a contest about which financial system can absorb more idiosyncratic risk over a longer horizon. The US system, on the evidence of the past five years, has become more concentrated in a smaller number of mega-cap issuers, more dependent on a narrow band of liquidity-providing institutions, and more vulnerable to the kind of correlation spike that August 2024 briefly previewed. The Chinese system, on the evidence of the same five years, has become more capable of pricing and absorbing risk in sectors the state has chosen to prioritise, and less dependent on the goodwill of foreign underwriters and foreign exchanges. Neither system is plainly superior. Each is well adapted to a different theory of how a great power should run its industrial base.
What the source items do not resolve is whether the parallel stacks are compatible, in the sense that a Chinese EV, a Chinese AI lab, and a Chinese launch operator can list in Hong Kong or Shanghai and still raise meaningful dollar-denominated capital from US-domiciled funds. The HKEX's Stock Connect regime, the STAR Market's limited foreign-investor access, and the US Treasury's continuing use of the entity-list as a capital-flow instrument all sit on top of the same underlying question. If they are compatible, the two systems will continue to interpenetrate at the margins, and the 11 June stories will read, in retrospect, as ordinary market notes. If they are not, the same stories will read as the first dispatches from a financial decoupling that has migrated, over a single decade, from the customs house to the underwriting desk.
The SCMP and Nikkei Asia items, taken together, show the US–China technology contest in transition. The Western wire has framed the day as "China insures its rockets, US lists its AI labs." The structural reading is sharper than that: the question is no longer who leads in compute and orbit, but whose financial system can carry the cost of leading.
Sources
Wire provenance
This editorial synthesis draws on the following public wire/social posts:
- https://t.me/SCMPNews
- https://t.me/NikkeiAsia